PACB R&D to Revenue
Pacific Biosciences Of California · R&D to Revenue
PACB R&D to Revenue
Latest reported59.02%period ending
PACB Quarterly R&D/Revenue (0.00% → 59.02%)
Latest values, visible window
High-resolution chart · PNG
PACB r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 59.0202% | |
| 52.7409% | |
| 51.2465% | |
| 59.4313% | |
| 56.6539% | |
| 78.1983% | |
| 70.0235% | |
| 63.8427% | |
| 106.8642% | |
| 111.9686% | |
| 76.3302% | |
| 85.3172% | |
| 97.0572% | |
| 125.8072% | |
| 155.8257% | |
| 145.746% | |
| 141.9573% | |
| 159.5786% | |
| 118.2043% | |
| 78.8489% | |
| 72.7409% | |
| 70.8625% | |
| 64.2136% | |
| 86.296% | |
| 87.896% | |
| 97.7689% | |
| 51.1028% | |
| 68.2729% | |
| 60.5581% | |
| 94.277% | |
| 83.2889% | |
| 79.0529% | |
| 72.5925% | |
| 84.2423% | |
| 62.6669% | |
| 67.2924% | |
| 84.108% | |
| 68.1156% | |
| 63.1949% | |
| 69.5875% | |
| 84.4556% | |
| 85.5388% | |
| 40.6604% | |
| 116.1314% | |
| 60.3192% | |
| 82.0799% | |
| 72.9472% | |
| 56.6988% | |
| 108.8403% | |
| 101.1081% | |
| 121.8853% | |
| 140.3989% | |
| 193.1548% | |
| 214.8261% | |
| 198.2307% | |
| 454.8271% | |
| 154.6016% | |
| 120.273% | |
| 99.767% | |
| 190.1416% | |
| 183.8758% | |
| 8,932.5926% | |
| 9,479.2857% | |
| 14,942.2727% | |
| 4,305.5644% | |
| 4,646.6055% | |
| 18,272.5926% | |
| 0% |